We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 62 results
  1. LncRNA LINC01133 Targeting miR-141-5p to Mediate the Progression and Ameliorate Poor Prognosis of Prostate Cancer

    Abstract

    Prostate cancer is a slowly progressive cancer that develops in the epithelial cells of the prostate, which is prone to bone metastasis. In...

    Y. Y. Li, Y. N. Zhang in Russian Journal of Genetics
    Article 01 December 2023
  2. A review on the role of LINC01133 in cancers

    Long Intergenic Non-Protein Coding RNA 1133 (LINC01133) is a long non-coding RNA (lncRNA) which interacts with miR-106a-3p, miR-576-5p, miR-495-3p,...

    Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, ... Majid Mokhtari in Cancer Cell International
    Article Open access 30 August 2022
  3. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis

    Purpose

    Pancreatic adenocarcinoma (PAAD) remains a highly aggressive gastrointestinal malignancy with a dismal prognosis. Pyroptosis has a key role in...

    **gwei Li, Jiewei Lin, ... Baiyong Shen in Cellular Oncology
    Article Open access 04 May 2023
  4. Genome instability-related LINC02577, LINC01133 and AC107464.2 are lncRNA prognostic markers correlated with immune microenvironment in pancreatic adenocarcinoma

    Background

    Pancreatic adenocarcinoma (PAAD) is a leading cause of malignancy-related deaths worldwide, and the efficacy of immunotherapy on PAAD is...

    Yinjiang Zhang, Yao Wang, ... Zongran Pang in BMC Cancer
    Article Open access 12 May 2023
  5. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer

    Background

    Luminal breast cancer (BC) is the most frequent subtype accounting for more than 70% of BC. LncRNAs, a class of non-coding RNAs with more...

    Sepideh Mehrpour Layeghi, Maedeh Arabpour, ... Rezvan Esmaeili in Journal of Translational Medicine
    Article Open access 26 August 2021
  6. Annotation and functional characterization of long noncoding RNAs deregulated in pancreatic adenocarcinoma

    Purpose

    Transcriptome analysis of pancreatic ductal adenocarcinoma (PDAC) has been useful to identify gene expression changes that sustain malignant...

    Vinicius Ferreira da PaixĂŁo, Omar Julio Sosa, ... Eduardo Moraes Reis in Cellular Oncology
    Article 14 May 2022
  7. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway

    Background

    Gastric cancer (GC) is a common malignancy and frequent cause of cancer-related death. Long non-coding RNAs (lncRNAs) have emerged as...

    **an-Zi Yang, Tian-Tian Cheng, ... Shu-Zhong Cui in Molecular Cancer
    Article Open access 22 August 2018
  8. PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression

    Surgery and chemo-radiotherapy are used as the common first-line treatment options in many cancers. However, tumor relapse is observed in many cancer...

    Negin Taghehchian, Amirhosein Maharati, ... Meysam Moghbeli in Cancer Cell International
    Article Open access 08 October 2023
  9. Transcriptome profiling and co-expression network analysis of lncRNAs and mRNAs in colorectal cancer by RNA sequencing

    Background

    Long non-coding RNAs (lncRNAs ) are widely involved in the pathogenesis of cancers. However, biological roles of lncRNAs in occurrence and...

    Mingjie Li, Dandan Guo, ... Yan’an Wu in BMC Cancer
    Article Open access 16 July 2022
  10. Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression

    Breast cancer (BC) as one of the most common causes of human deaths among women, is always considered one of the global health challenges. Despite...

    Amirhosein Maharati, Meysam Moghbeli in Journal of Translational Medicine
    Article Open access 18 August 2023
  11. KRAS-related long noncoding RNAs in human cancers

    KRAS is one of the most widely prevalent proto-oncogenes in human cancers. The constitutively active KRAS oncoprotein contributes to both tumor onset...

    Mahsa Saliani, Amin Mirzaiebadizi, ... Mohammad Reza Ahmadian in Cancer Gene Therapy
    Article Open access 06 September 2021
  12. Functional interplay between long non-coding RNAs and Breast CSCs

    Breast cancer (BC) represents aggressive cancer affecting most women’s lives globally. Metastasis and recurrence are the two most common factors in a...

    Bashdar Mahmud Hussen, Ramiar Kamal Kheder, ... Soudeh Ghafouri-Fard in Cancer Cell International
    Article Open access 21 July 2022
  13. Current concepts of microRNA-mediated regulatory mechanisms in human pulp tissue-derived stem cells: a snapshot in the regenerative dentistry

    One of the most studied class of non-coding RNAs is microRNAs (miRNAs) which regulate more than 60% of human genes. A network of miRNA gene...

    Mohammad Hasan Soheilifar, Sima Nobari, ... Hoda Keshmiri Neghab in Cell and Tissue Research
    Article 29 May 2023
  14. Long non-coding RNA signature in colorectal cancer: research progression and clinical application

    Colorectal cancer is one of the top-ranked human malignancies. The development and progression of colorectal cancer are associated with aberrant...

    Yudi Wu, **angshang Xu in Cancer Cell International
    Article Open access 16 February 2023
  15. Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview

    Colorectal cancer (CRC) is the second most common cause of cancer mortality and a major health challenge worldwide. Despite advances in therapeutic...

    Amir Abbas Hamidi, Ghazaleh Khalili-Tanha, ... Meysam Moghbeli in Cancer Cell International
    Article Open access 10 February 2022
  16. Noncoding RNAs regulate alternative splicing in Cancer

    AS (alternative splicing) is a fundamental process by which a gene can generate multiple distinct mRNA transcripts to increase protein diversity....

    Yunze Liu, **n Liu, ... Yi Zhang in Journal of Experimental & Clinical Cancer Research
    Article Open access 06 January 2021
  17. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance

    The metastasis is a multistep process in which a small proportion of cancer cells are detached from the colony to enter into blood cells for...

    Zhenli Guo, Milad Ashrafizadeh, ... **anbin Zhang in Cancer and Metastasis Reviews
    Article 15 July 2023
  18. miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer

    Background

    Colorectal cancer is one of the most common malignancy in the world. It has been reported that cancer stem cells (CSCs) serve as the...

    Yifan Li, **g Xun, ... Qi Zhang in Journal of Translational Medicine
    Article Open access 16 October 2021
  19. Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo

    Background

    Long non-coding RNAs (lncRNAs) are involved in the development of hepatocellular carcinoma (HCC). We aimed to investigate the function of...

    **aoyun Ma, Meile Mo, ... **aoqiang Qiu in Journal of Translational Medicine
    Article Open access 31 January 2022
  20. Long non-coding RNAs are involved in alternative splicing and promote cancer progression

    Alternative splicing (AS) is a key process in which precursor RNAs produce different mature RNAs, and the disorder of AS is a key factor in promoting...

    Jiawei Ouyang, Yu Zhong, ... Wei **ong in British Journal of Cancer
    Article Open access 08 November 2021
Did you find what you were looking for? Share feedback.